Identification of endoscopic findings predicting the appearance of map-like redness after Helicobacter pylori eradication therapy: Multicenter prospective study

Identification of endoscopic findings predicting the appearance of map-like redness after Helicobacter pylori eradication therapy: Multicenter prospective study - Map-like reddish endoscopic appearance prediction marker

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044707

Enrollment

129

Registered

2021-07-01

Start date

2021-06-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H. pylori positive gastritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. H. pylori positive patients aged 20 years 2. Performance status; 0 and 1 point 3. Patients receiving informed consent

Exclusion criteria

Exclusion criteria: 1. patients with serious complications (heart failure, liver failure, respiratory failure) 2. Pregnant or lactating 3. Patients who are taking two or more types of antithrombotic drugs

Design outcomes

Primary

Measure	Time frame
To identify endoscopic findings that predict the appearance of map-like redness before H. pylori eradication therapy	—

Secondary

Measure	Time frame
(1) Occurrence rate of map-like redness after H. pylori eradication treatment (2) Appearance site of map-like redness after eradication therapy (3) Prediction of the appearance of map-like redness Identification of an excellent IEE method for detecting endoscopic findings (4) Differences of endoscopy models to evaluate map-like redness (5) Histopathological examination of appearance prediction part before eradication treatment (6) Correlation between the appearance of map-like redness and pepsinogen levels (7) Relationship between map-like redness and Kyoto gastritis classification	—

Measure

Time frame

(1) Occurrence rate of map-like redness after H. pylori eradication treatment (2) Appearance site of map-like redness after eradication therapy (3) Prediction of the appearance of map-like redness Identification of an excellent IEE method for detecting endoscopic findings (4) Differences of endoscopy models to evaluate map-like redness (5) Histopathological examination of appearance prediction part before eradication treatment (6) Correlation between the appearance of map-like redness and pepsinogen levels (7) Relationship between map-like redness and Kyoto gastritis classification

—

Countries

Japan

Contacts

Public ContactMitsushige Sugimoto

Tokyo Medical University Hospital Department of Gastroenterological Endoscopy

sugimo@tokyo-med.ac.jp03-3342-6111

Outcome results